NCT00543036

Brief Summary

Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 12, 2007

Completed
Last Updated

October 12, 2007

Status Verified

August 1, 2007

First QC Date

October 11, 2007

Last Update Submit

October 11, 2007

Conditions

Marijuana Abuse

Keywords

CannabisAddictionCravingTMS

Interventions

H-Coil deep TMSDEVICE

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis abuse and are motivated to quit cannabis use as assessed in the screening visit and gave their written informed consent to participate in the study.

You may not qualify if:

  • History of a primary major psychiatric other then cannabis abuse, or cognitive disorder according to DSM-IV TR criteria.
  • Hamilton depression scale rated 25 and above (moderate to severe depression)
  • Current alcohol or other substance abuse or dependence
  • Alcohol or other substance abuse or dependence during the last 12 months before recruitment.
  • History of or evidence of significant brain malformation,neoplasm, head injury, cerebral vascular events,neurodegenerative disorder or brain surgery.
  • Severe somatic co-morbidity
  • History of seizures Cardiac pace maker or other electronic implants Pregnancy and lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shalvata Mental Health Center

Hod HaSharon, 45100, Israel

RECRUITING

MeSH Terms

Conditions

Marijuana AbuseBehavior, Addictive

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersCompulsive BehaviorImpulsive BehaviorBehavior

Study Officials

  • Ziv Carmel, M.D

    Shalvata MHC affiliated to Tel-Aviv universtiy, Sackler school of medicine

    PRINCIPAL INVESTIGATOR

  • Abraham Zangen, Ph.D.

    Weizmann Institute, Rehovot, Israel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ziv Carmel, M.D.

CONTACT

+972-9-7478570zivca@clalit.org.il

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 11, 2007

First Posted

October 12, 2007

Last Updated

October 12, 2007

Record last verified: 2007-08

Locations

IL(1)